UNVERIFIEDStat NewsSingle SourceAs FDA misses deadline on electric shock ban, disability advocates speak outOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: Medicare’s mum on GLP-1s, and Massachusetts sues United Open summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and moreOpen summary →
UNVERIFIEDStat NewsSingle SourceOpinion: What should hospitals do when patients demand unvaccinated donor blood?Open summary →
UNVERIFIEDStat NewsSingle SourceCDC says containing the spread of Ebola is top priorityOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: Servier to buy Edgewise Therapeutics’ muscular dystrophy drugOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: Medicare still won’t say how much covering obesity drugs will costOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: No Surprises Act arbitration rule could worsen flood of provider disputesOpen summary →
UNVERIFIEDStat NewsSingle SourceKenya court suspends U.S. plan for Ebola quarantine facility for AmericansOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: A standing ovation for RevMed, and caution for AkesoOpen summary →
UNVERIFIEDStat NewsSingle SourceUltra-low doses could bring costly cancer treatments to more patients in poorer countriesOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study findsOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: Akeso and Summit’s ivonescimab extends survival in squamous cell lung cancerOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: Practice-changing results reported for Revolution Medicines pancreatic cancer drugOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: BioNTech and Pfizer tout bispecifics data at ASCO, and Pazdur sees silver lining at FDAOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: China competition, ‘destruction’ at FDA gives agency chance to restructure, Rick Pazdur saysOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: Revolution Medicines starts shipping experimental pancreatic cancer drugOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: As Ebola outbreak grows, Trump administration veers from previous government playbookOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancerOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: Trump administration seeks to overhaul federal grantmaking process, alarming researchersOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and moreOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: Massachusetts sues UnitedHealth, alleging fraud in state’s Medicaid plans for seniorsOpen summary →
UNVERIFIEDStat NewsSingle SourceWhich vaccines will curb the Ebola outbreak? WHO debatesOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: Up and down the ladder: The latest comings and goingsOpen summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: The woman behind the world’s biggest longevity competitionOpen summary →
UNVERIFIEDStat NewsSingle SourceOpinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’Open summary →
UNVERIFIEDStat NewsSingle SourceSTAT+: As Ebola outbreak in Central Africa grows, the U.S. turns itself into a fortressOpen summary →